A
DAWN

AJOVista’s Day One Biopharmaceuticals DAWN Stock Holding History

AJOVista’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$150K Buy
+10,742
New +$153K 0.64% 60

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJOVista's DAWN Position: Q3 2024 in Review

AJOVista opened a new position in Day One Biopharmaceuticals (DAWN) in Q3 2024: 10,742 shares worth $150K. The stake represents 0.64% of the portfolio and ranks #60 among its holdings.

166 funds tracked by Wall St. Rank hold DAWN as of Q3 2024.

  • AJOVista held 10,742 shares of Day One Biopharmaceuticals worth $150K as of Q3 2024.
  • Day One Biopharmaceuticals was a new AJOVista position in Q3 2024.
  • Day One Biopharmaceuticals made up 0.64% of AJOVista's portfolio in Q3 2024, its #60 holding.
  • 166 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.